Free Trial
→ Buffett’s $325 Billion Cash Problem — Solved by Gold? (From Golden Portfolio) (Ad)

3 High-Growth Stocks Traders Love and Investors Should Watch

Chris Markoch
Written by Chris Markoch | Reviewed by Shannon Tokheim
June 5, 2025

Key Points

  • TransMedics Group is a leader in organ transplant logistics, drawing interest from traders and long-term investors.
  • SMR stock is up 78% this year, fueled by DoE contracts and rising demand for nuclear energy as AI drives power needs higher.
  • DAVE stock has soared over 120% in 2025 and 2,600% since 2023, driven by its fintech solutions that appeal to underserved banking customers.
  • Five stocks to consider instead of NuScale Power.

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Upgrade Now See Benefits

Already have an account? Log in here.

Should You Invest $1,000 in NuScale Power Right Now?

Before you consider NuScale Power, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NuScale Power wasn't on the list.

While NuScale Power currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover
Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Chris Markoch
About The Editor

Chris Markoch

Editor & Contributing Author

Retirement, Individual Investing

Learn More about Chris Markoch
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
TransMedics Group (TMDX)
1.7331 of 5 stars		$137.33+1.3%N/A146.15Moderate Buy$125.11
NVIDIA (NVDA)
4.706 of 5 stars		$142.51+1.8%0.03%56.08Moderate Buy$171.66
Dave (DAVE)
3.163 of 5 stars		$220.35+5.3%N/A70.08Buy$189.00
NuScale Power (SMR)
2.0098 of 5 stars		$33.86+9.0%N/A-35.69Moderate Buy$27.00
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
May 29, 2025

NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant

NVIDIA’s stock just surged again after another earnings beat—but legendary trader Tim Sykes says the real money is in the companies NVIDIA invests in.

Watch Video

Related Videos

NVIDIA Earnings Preview: HUGE Stock Move Ahead
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
New AI Deals Just Sent These 4 Infrastructure Stocks Soaring

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines